Biomea Fusion

About:

Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.

Website: https://www.biomeafusion.com/

Twitter/X: biomeafusion

Top Investors: Cormorant Asset Management, RTW Investments, Janus Henderson Investors, Rock Springs Capital, Logos Capital

Description:

Biomea Fusion is a privately held precision medicine company with a mission to revolutionize drug development to create more effective therapies for cancer patients. Biomea Fusion has a development portfolio that targets specific gene alterations which occur in the DNA of patients that translate into key drivers of tumor growth. It is Biomea’s goal to move these potentially breakthrough medicines swiftly through the development process and deliver highly impactful treatments for patients in need. The lead program targets the protein-to-protein interaction between menin and the MLL complex for the treatment of various tumors.